Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$18.4K Sell
7,907
-16,697
-68% -$33.4K ﹤0.01% 1388
2024
Q4
$45.5K Buy
24,604
+12,660
+106% +$28K ﹤0.01% 852
2024
Q3
$29.1K Buy
11,944
+310
+3% +$695 ﹤0.01% 1085
2024
Q2
$23.9K Buy
11,634
+3,455
+42% +$7.87K ﹤0.01% 1140
2024
Q1
$20.3K Sell
8,179
-438
-5% -$1.14K ﹤0.01% 1200
2023
Q4
$24.1K Buy
8,617
+631
+8% +$1.7K ﹤0.01% 1081
2023
Q3
$20.6K Buy
7,986
+2,812
+54% +$8.13K ﹤0.01% 1048
2023
Q2
$16.5K Buy
5,174
+368
+8% +$1.08K ﹤0.01% 1194
2023
Q1
$13.6K Sell
4,806
-2,412
-33% -$6.31K ﹤0.01% 1265
2022
Q4
$19.6K Buy
7,218
+2,445
+51% +$7.12K ﹤0.01% 1073
2022
Q3
$14K Buy
4,773
+1,969
+70% +$5.58K ﹤0.01% 1151
2022
Q2
$7K Sell
2,804
-589
-17% -$1.68K ﹤0.01% 1382
2022
Q1
$11K Sell
3,393
-800
-19% -$2.23K ﹤0.01% 1235
2021
Q4
$12K Buy
4,193
+202
+5% +$579 ﹤0.01% 1186
2021
Q3
$11K Buy
3,991
+450
+13% +$1.43K ﹤0.01% 940
2021
Q2
$12K Buy
3,541
+197
+6% +$641 ﹤0.01% 967
2021
Q1
$9K Buy
3,344
+1,518
+83% +$4.29K ﹤0.01% 1040
2020
Q4
$6K Sell
1,826
-2,482
-58% -$6.69K ﹤0.01% 1091
2020
Q3
$10K Buy
4,308
+3,049
+242% +$7.65K ﹤0.01% 819
2020
Q2
$3K Sell
1,259
-7,769
-86% -$18.3K ﹤0.01% 1227
2020
Q1
$21K Buy
9,028
+6,912
+327% +$25K 0.01% 520
2019
Q4
$10K Sell
2,116
-1,167
-36% -$5.18K ﹤0.01% 918
2019
Q3
$15K Buy
3,283
+1,501
+84% +$7.19K 0.01% 783
2019
Q2
$8K Buy
1,782
+602
+51% +$2.7K ﹤0.01% 939
2019
Q1
$5K Hold
1,180
﹤0.01% 1063
2018
Q4
$4K Buy
+1,180
New +$5.04K ﹤0.01% 1045

Other funds holding ABEV

Lindbrook Capital's ABEV Position: Q1 2025 in Review

Lindbrook Capital reduced its Ambev (ABEV) stake by 68% in Q1 2025, selling an estimated $33.4K and leaving 7,907 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1388.

Lindbrook Capital first reported a position in ABEV in Q4 2018 and has held it in 26 quarters since. The position peaked at $45.5K in Q4 2024. 362 funds tracked by Wall St. Rank hold ABEV as of Q1 2025.

  • Lindbrook Capital held 7,907 shares of Ambev worth $18.4K as of Q1 2025.
  • Lindbrook Capital sold 16,697 Ambev shares in Q1 2025, an estimated $33.4K.
  • Ambev made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1388 holding.
  • Lindbrook Capital first reported a position in Ambev in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Ambev position peaked at $45.5K in Q4 2024.
  • 362 funds tracked by Wall St. Rank held Ambev as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.